Indegene Ltd.

₹567.3

Indegene Ltd.

₹567.3

₹567.3

-6.85 (-1.19%) - 10 Jul 2025 10:07 AM

About Company

Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its solutions enable life sciences companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner. It achieves this by combining over two decades of healthcare domain expertise and fit-for purpose technology. 

Market Cap. ₹ 13,784 Cr.
52 Week - High/Low ₹ 736/499
P/E Ratio 75.75
P/B Ratio 7.30
Enterprise Value ₹ 13,670 Cr.
ROE % 13.07
RSI Value 44.72
EMA 50 578.51
EMA 200 586.8
Market Cap. ₹ 13,784 Cr.
52 Week - High/Low ₹ 736/499
P/E Ratio 33.77
P/B Ratio 5.27
Enterprise Value ₹ 13,465 Cr.
ROE % 20.45
RSI Value 44.72
EMA 50 578.51
EMA 200 586.8

Growth

Valuation

Calculators

Peer Comparison

Industry - Business Support

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.